FDA Comes Under Fire From Sen. Clinton Over Plan B Decision
This article was originally published in The Tan Sheet
Executive Summary
Sen. Hillary Clinton (D-N.Y.) is calling for a hearing and separate GAO investigation into FDA's decision to deny OTC approval of Barr's Plan B (levenorgestrel) emergency contraceptive
You may also be interested in...
GAO Draft Report Finds Plan B Rejection “Unusual”; Lawmakers Urge Decision
The Government Accountability Office's investigation into FDA's initial denial of Plan B discovered that the agency's decision to issue a "not approvable" letter did not reflect the opinions of scientific review staff.
GAO Draft Report Finds Plan B Rejection “Unusual”; Lawmakers Urge Decision
The Government Accountability Office's investigation into FDA's initial denial of Plan B discovered that the agency's decision to issue a "not approvable" letter did not reflect the opinions of scientific review staff.
GAO Draft Report Finds Plan B Rejection “Unusual”; Lawmakers Urge Decision
The Government Accountability Office's investigation into FDA's initial denial of Plan B discovered that the agency's decision to issue a "not approvable" letter did not reflect the opinions of scientific review staff.